HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$8.96
Day range
$8.77 - $9.11
Year range
$4.09 - $17.58
Market cap
476.70M USD
Avg Volume
753.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.89M | 47.94% |
Operating expense | 34.90M | 14.26% |
Net income | -26.43M | -7.69% |
Net profit margin | -540.05 | 27.21% |
Earnings per share | -0.47 | 14.55% |
EBITDA | -29.46M | -10.78% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 239.20M | 11.40% |
Total assets | 293.32M | 22.27% |
Total liabilities | 61.21M | -8.50% |
Total equity | 232.11M | — |
Shares outstanding | 52.97M | — |
Price to book | 2.05 | — |
Return on assets | -24.96% | — |
Return on capital | -30.87% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -26.43M | -7.69% |
Cash from operations | -21.62M | -25.22% |
Cash from investing | -30.00M | -305.27% |
Cash from financing | 8.16M | 1,351.78% |
Net change in cash | -43.46M | -1,986.41% |
Free cash flow | -4.77M | 34.75% |
About
Founded
2014
Headquarters
Website
Employees
110
